Trial intelligence / Profile preview

Purethal Mites Immunotherapy in Elderly Allergic Rhinitis

NCT03209245Phase 3Completed

Sponsor
Medical University of Silesia
Start
Apr 2014
Primary completion
Jun 2016
Modality
Allergy Immunotherapy
01

Overview

A Phase 3 trial of PURETHAL Mites in allergic rhinitis (AR), sponsored by Medical University of Silesia. Started Apr 2014; status: completed.

02

Drugs

PURETHAL Mites
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT03209245.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03209245.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call